Mitumomab

WikiDoc Resources for Mitumomab
Articles
Most recent articles on Mitumomab Most cited articles on Mitumomab Review articles on Mitumomab Articles on Mitumomab in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Mitumomab Images of Mitumomab Photos of Mitumomab Podcasts & MP3s on Mitumomab Videos on Mitumomab
Evidence Based Medicine
Cochrane Collaboration on Mitumomab Bandolier on Mitumomab TRIP on Mitumomab
Clinical Trials
Ongoing Trials on Mitumomab at Clinical Trials.gov Trial results on Mitumomab Clinical Trials on Mitumomab at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Mitumomab NICE Guidance on Mitumomab NHS PRODIGY Guidance FDA on Mitumomab CDC on Mitumomab
Books
Books on Mitumomab
News
Mitumomab in the news Be alerted to news on Mitumomab News trends on Mitumomab
Commentary
Blogs on Mitumomab
Definitions
Definitions of Mitumomab
Patient Resources / Community
Patient resources on Mitumomab Discussion groups on Mitumomab Patient Handouts on Mitumomab Directions to Hospitals Treating Mitumomab Risk calculators and risk factors for Mitumomab
Healthcare Provider Resources
Symptoms of Mitumomab Causes & Risk Factors for Mitumomab Diagnostic studies for Mitumomab Treatment of Mitumomab
Continuing Medical Education (CME)
CME Programs on Mitumomab
International
Mitumomab en Espanol Mitumomab en Francais
Business
Mitumomab in the Marketplace Patents on Mitumomab
Experimental / Informatics
List of terms related to Mitumomab

Overview

Mitumomab is a mouse, anti-Idiotypic monoclonal antibody that targets GD3 ganglioside, which is over-expressed predominantly on tumours origination from the neuroectoderm.

Template:Mousemonoclonals Template:WH Template:WikiDoc Sources